Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Danijela, Jelovac"'
Autor:
Jennifer L. Wolff, Jennifer Aufill, Diane Echavarria, Amanda L. Blackford, Roisin M. Connolly, John H. Fetting, Danijela Jelovac, Katie Papathakis, Carol Riley, Vered Stearns, Nelli Zafman, Elissa Thorner, Howard P. Levy, Amy Guo, Sydney M. Dy, Antonio C. Wolff
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract We examined the effects of a communication intervention to engage family care partners on patient portal (MyChart) use, illness understanding, satisfaction with cancer care, and symptoms of anxiety in a single-blind randomized trial of patie
Externí odkaz:
https://doaj.org/article/27348f3d9c744b538a162f60f57d5131
Autor:
Mehran Habibi, Danijela Jelovac, Rima Couzi, Cesar Augusto Santa-Maria, Catherine Klein, Marissa White, Nivali Naik, Jennifer Wei, Yen Huynh, Architha Ellappalayam, Lisa E. Blumencranz, Erin B. Yoder, Patricia Dauer, Bas van der Baan, William Audeh
Publikováno v:
Cancer Research. 83:P5-09
BACKGROUND: Neoadjuvant Endocrine Therapy (NET) is seldom used in breast cancer management except in patients with several comorbidities or in elderly patients in which chemotherapy is not an option. Clinical response with NET is not typically achiev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b353b079d2d3eb9a3f168706e7b5efc4
https://doi.org/10.1158/1538-7445.sabcs22-p5-09-02
https://doi.org/10.1158/1538-7445.sabcs22-p5-09-02
Autor:
Ben Ho Park, Antonio C. Wolff, Pedram Argani, Ashley Cimino-Mathews, Leslie Cope, Dianna Maar, Michael L. Samuels, Stacie Jeter, Jill Kessler, Dustin A. VanDenBerg, Josh Lauring, Paula J. Hurley, Julie Lange, Mehran Habibi, Lisa Jacobs, Vered Stearns, Michaela J. Higgins, Timothy Burns, David Chu, Brian G. Blair, Justin Cidado, Patricia Valda Toro, Hong Yuen Wong, Daniel J. Zabransky, Sarah Croessmann, Rory L. Cochran, Sasidharan Balukrishna, Danijela Jelovac, Julia A. Beaver
PDF file - 395KB, Figure S1. Pre-surgery plasma ddPCR analysis for PIK3CA mutations. Figure S2. Positive and negative controls for droplet thresholds and counts. Figure S3. Lower Limit of Detection for PIK3CA Exon 9. Supplementary Table S1: Primers u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b88ec1788ebceb33dc2a7e31c947899
https://doi.org/10.1158/1078-0432.22449798
https://doi.org/10.1158/1078-0432.22449798
Autor:
Ben Ho Park, Antonio C. Wolff, Pedram Argani, Ashley Cimino-Mathews, Leslie Cope, Dianna Maar, Michael L. Samuels, Stacie Jeter, Jill Kessler, Dustin A. VanDenBerg, Josh Lauring, Paula J. Hurley, Julie Lange, Mehran Habibi, Lisa Jacobs, Vered Stearns, Michaela J. Higgins, Timothy Burns, David Chu, Brian G. Blair, Justin Cidado, Patricia Valda Toro, Hong Yuen Wong, Daniel J. Zabransky, Sarah Croessmann, Rory L. Cochran, Sasidharan Balukrishna, Danijela Jelovac, Julia A. Beaver
Purpose: Detecting circulating plasma tumor DNA (ptDNA) in patients with early-stage cancer has the potential to change how oncologists recommend systemic therapies for solid tumors after surgery. Droplet digital polymerase chain reaction (ddPCR) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07557c69ad2cac686a1d97cf5f134f96
https://doi.org/10.1158/1078-0432.c.6521754
https://doi.org/10.1158/1078-0432.c.6521754
Autor:
Ben Ho Park, Josh Lauring, Pedram Argani, Yoshitaka Hosokawa, Akinobu Ota, Yuko Konishi, Sivasundaram Karnan, Rory L. Cochran, Sarah Croessmann, Danijela Jelovac, Justin Cidado, Michaela J. Higgins, Morassa Mohseni, Joseph P. Garay, William Matsui, Zeshaan Rasheed, Samuel Ray Denmeade, D. Marc Rosen, John P. Gustin, Abde M. Abukhdeir, Brian G. Blair, Hiroyuki Konishi, Hong Yuen Wong, Grace M. Wang
PDF file - 1480K, Figure S1. Double knock in clones have single mutant PIK3CA alleles and equivalent expression of mutant and wild type PIK3CA and form aberrant structures in 3D culture. Figure S2. DKI xenografts retain the same number of KRAS and PI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cbb464b436aa1e0e0399e735863603e
https://doi.org/10.1158/0008-5472.22397007
https://doi.org/10.1158/0008-5472.22397007
Autor:
F. Asrari, Amanda L. Blackford, Mehran Habibi, Zohaib Akhtar, Danijela Jelovac, Vered Stearns, Paul Cartwright, Catherine Klein, Vishnu Prasath
Publikováno v:
Breast Cancer Research and Treatment. 182:623-629
A delay in breast cancer treatment is associated with inferior survival outcomes; however, no clear guidelines exist defining the appropriate time frame from diagnosis to definitive treatment of breast cancer. A multidisciplinary approach for breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5f8153d36fb2d0b64debbc96b549395
https://doi.org/10.1007/s10549-020-05721-3
https://doi.org/10.1007/s10549-020-05721-3
Autor:
Christopher J. Darus, Danijela Jelovac, Linda R. Duska, Gina R. Petroni, Lisa Barroilhet, Jubilee Brown, Nikole Varhegyi, Kathleen N. Moore, Angeles Alvarez Secord, William P. McGuire
Publikováno v:
Gynecologic Oncology. 157:585-592
Angiogenesis inhibition is a valuable strategy for ovarian cancer (EOC). Pazopanib (paz) is a potent small molecular inhibitor of VEGF-1, -2, -3, PDGFR, c-kit, and has activity as a single agent in ovarian cancer. We designed a trial to assess the be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eab2ff6d023daeab28e617f8741af219
https://doi.org/10.1016/j.ygyno.2019.10.014
https://doi.org/10.1016/j.ygyno.2019.10.014
Autor:
Vered Stearns, RM Connolly, Danijela Jelovac, Gary L. Rosner, Karen L. Smith, D-Y Lu, Zhe Zhang, Margaret Leathers, Jan M. Griffin, Antonio C. Wolff, Kala Visvanathan, Allison G. Hays, Stuart D. Russell, Theodore P. Abraham, H-L Tsai
Publikováno v:
Cancer Research. 79:P4-16
Background: Cardiac toxicity (CT) is a rare late effect of anthracycline therapy for breast cancer (BC). Statins may attenuate the CT of anthracyclines. Myocardial strain can detect subclinical CT before ejection fraction (EF) declines. Global longit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe6e20498991124179e6505fc3268b40
https://doi.org/10.1158/1538-7445.sabcs18-p4-16-09
https://doi.org/10.1158/1538-7445.sabcs18-p4-16-09
Autor:
Humaid, Al-Shamsi, Humaa, Darr, Ibrahim, Abu-Gheida, Jawaher, Ansari, Martine C, McManus, Hassan, Jaafar, Syed Hammad, Tirmazy, Maroun, Elkhoury, Fathi, Azribi, Danijela, Jelovac, Tarik A, Doufan, Abdel Rahman, Labban, Ahmad Ali, Basha, Ahmed, Samir, Aladdin, Maarraoui, Ali, Al Dameh, Aydah, Al-Awadhi, Basel, Al Haj Ali, Batool, Aboud, Dalia, Elshorbagy, Diaa, Trad, Dima, Abdul Jabbar, Dina, Hamza, Ed, Ashtar, Emad, Dawoud, Essa M, Aleassa, Faraz, Khan, Faryal, Iqbal, Hala, Abdellatif, Mehdi, Afrit, Mohamad H, Masri, Mohamed, Abuhaleeqa, Mohamed, Alfalasi, Mohamed, Omara, Mohanad, Diab, Muhammad Farooq, Latif, Muharram, Oner, Norbert, Dreier, Omar, Almarzouqi, R A, Singarachari, Riyad, Bendardaf, Sadir, Alrawi, Salman Sray, Aldeen, Shabeeha, Rana, Soha, Talima, Tamer, Abdelgawad, Abhinav, Ahluwalia, Thamir, Alkasab, Tamer, Madi, Tarek, Alkhouri, Urfan, Ul Haq, Yazan Z, Alabed, Mohamad, Azzam, Zulfaqqar, Ali, Maher A, Abbas, Aly Abdel, Razek, Falah, Al-Khatib
Publikováno v:
The Gulf journal of oncology. 1(32)
With cancer being the third leading cause of mortality in the United Arab Emirates (UAE), there has been significant investment from the government and private health care providers to enhance the quality of cancer care in the UAE. The UAE is a devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3d3a9ebacca8a0615322a4bf48da4c54
https://pubmed.ncbi.nlm.nih.gov/32342923
https://pubmed.ncbi.nlm.nih.gov/32342923
Autor:
Danijela Jelovac, Howard P. Levy, Kimberley T. Lee, Ja Alah Ai Heughan, Diane Echavarria, John H. Fetting, Sydney M. Dy, Roisin M. Connolly, Katie Papathakis, Jennifer Aufill, Jennifer L. Wolff, Antonio C. Wolff, Nelli Zafman, Elissa Thorner, Carol D. Riley, Vered Stearns
Publikováno v:
Breast Cancer Res Treat
PURPOSE: Family is often overlooked in cancer care. We developed a patient-family agenda setting intervention to engage family in cancer care communication. METHODS: We conducted a pilot randomized controlled trial (NCT03283553) of patients on active
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed0915c2568ff0b14fa130a8115bf4b
https://europepmc.org/articles/PMC6640103/
https://europepmc.org/articles/PMC6640103/